Literature DB >> 1735094

Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

A von Graevenitz1, D Amsterdam.   

Abstract

The process of continuous ambulatory peritoneal dialysis has provided a useful, relatively inexpensive, and safe alternative for patients with end-stage renal disease. Infectious peritonitis, however, has limited a more widespread acceptance of this technique. The definition of peritonitis in this patient population is not universally accepted and does not always include the laboratory support of a positive culture (or Gram stain). In part, the omission of clinical microbiological findings stems from the lack of sensitivity of earlier microbiological efforts. Peritonitis results from decreased host phagocytic efficiency with depressed phagocytosis and bactericidal capacity of peritoneal macrophages. During episodes of peritonitis, fluid movement is reversed, away from the lymphatics and peritoneal membrane and toward the cavity. As a result, bloodstream infections are rare. Most peritonitis episodes are caused by bacteria. Coagulase-negative staphylococci are the most frequently isolated organisms, usually originating from the skin flora, but a wide array of microbial species have been documented as agents of peritonitis. Clinical microbiology laboratories need to be cognizant of the diverse agents so that appropriate primary media can be used. The quantity of dialysate fluid that is prepared for culture is critical and should constitute at least 10 ml. The sensitivity of the cultural approach depends on the volume of dialysate, its pretreatment (lysis or centrifugation), the media used, and the mode of incubation. The low concentration of microorganisms in dialysate fluids accounts for negative Gram stain results. Prevention of infection in continuous ambulatory peritoneal dialysis patients is associated with the socioeconomic status of the patient, advances in equipment (catheter) technology, and, probably least important, the application of prophylactic antimicrobial agents.

Entities:  

Mesh:

Year:  1992        PMID: 1735094      PMCID: PMC358222          DOI: 10.1128/CMR.5.1.36

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  126 in total

1.  Early diagnosis of peritoneal infection during continuous ambulatory peritoneal dialysis by the dialysate-digest medium-tube method.

Authors:  K Záruba; M Oliveri
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

2.  Peritonitis due to Listeria monocytogenes complicating continuous ambulatory peritoneal dialysis.

Authors:  J P Myers; G Peterson; A Rashid
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

3.  Bacillus cereus as agent of peritonitis during peritoneal dialysis.

Authors:  S Biasioli; S Chiaramonte; A Fabris; M Feriani; E Pisani; C Ronco; D Borin; A Brendolan; G La Greca
Journal:  Nephron       Date:  1984       Impact factor: 2.847

4.  Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies.

Authors:  R Gokal; J M Ramos; D M Francis; R E Ferner; T H Goodship; G Proud; A J Bint; M K Ward; D N Kerr
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

5.  Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.

Authors:  W F Keane; C M Comty; H A Verbrugh; P K Peterson
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

6.  Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis.

Authors:  H A Verbrugh; W F Keane; J R Hoidal; M R Freiberg; G R Elliott; P K Peterson
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

7.  Group JK corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  D Pierard; S Lauwers; M C Mouton; J Sennesael; D Verbeelen
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

8.  Peritonitis in continuous ambulatory peritoneal dialysis patients.

Authors:  J Rubin; R Ray; T Barnes; N Teal; E Hellems; J Humphries; J D Bower
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860

9.  Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy.

Authors:  T J Marrie; M A Noble; J W Costerton
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

10.  Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.

Authors:  R Krothapalli; W B Duffy; C Lacke; W Payne; H Patel; V Perez; H O Senekjian
Journal:  Arch Intern Med       Date:  1982-10
View more
  26 in total

1.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

2.  Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  M P Romero Gómez; A García-Perea; G Ruiz Carrascoso; M A Bajo; J Mingorance
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

3.  Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis.

Authors:  L Pei; M Palma; M Nilsson; B Guss; J I Flock
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Peritonitis due to CDC coryneform group A-4 in a patient undergoing continuous cycling peritoneal dialysis.

Authors:  J Esteban; R Calvo; F Gutierrez; F Soriano; A Ortiz; A Reyero-Lopez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

5.  Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.

Authors:  K Sieradzki; R B Roberts; D Serur; J Hargrave; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

6.  Comparison of BacT/Alert blood culture bottles with lytic media for culture of peritoneal dialysis fluid.

Authors:  J Wüst; A von Graevenitz
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

Review 7.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

8.  Molecular identification of Pasteurella dagmatis peritonitis in a patient undergoing peritoneal dialysis.

Authors:  F Wallet; F Touré; A Devalckenaere; D Pagniez; R J Courcol
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

9.  Microbiology and outcomes of peritonitis in northern India.

Authors:  Kashi Nath Prasad; Kamini Singh; Arshi Rizwan; Priyanka Mishra; Dinesh Tiwari; Narayan Prasad; Amit Gupta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Neisseria meningitidis serogroup B peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  G Conrads; G Haase; N Schnitzler; I Ehrhard; H Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.